Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 113 | 228 | 392 | 138 | 99 |
| Cost of Goods | 9 | 1 | 0 | N/A | 26 |
| Gross Profit | 104 | 228 | 392 | 138 | 73 |
| Operating Expenses | 594 | 559 | 466 | 348 | 430 |
| Operating Income | -481 | -330 | -74 | -210 | -330 |
| Interest Expense | 0 | 6 | 0 | 0 | 0 |
| Other Income | -13 | 3 | -18 | 0 | 0 |
| Pre-tax Income | -495 | -334 | -92 | -210 | -330 |
| Net Income Continuous | -495 | -334 | 238 | -210 | -330 |
| Net Income Discontinuous | N/A | N/A | -486 | -93 | 1,482 |
| Net Income | $-495 | $-334 | $-248 | $-303 | $1,152 |
| EPS Basic Total Ops | -0.56 | -0.42 | -0.28 | -0.28 | 1.26 |
| EPS Basic Continuous Ops | -0.56 | -0.38 | 0.43 | -0.28 | -0.42 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.56 | -0.14 | 1.68 |
| EPS Diluted Total Ops | -0.56 | -0.42 | -0.28 | -0.28 | 1.26 |
| EPS Diluted Continuous Ops | -0.56 | -0.38 | 0.43 | -0.28 | -0.42 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.56 | -0.14 | 1.68 |
| EBITDA(a) | $-445 | $-293 | $-24 | $-107 | $-320 |